Gemma Cholerton

Qinecsa COO, John Cogan, has been featured in Pharmaceutical Outsourcing’s latest issue, where he discusses why adverse event case processing is an enormous cost center

Qinecsa CEO, Adam Sherlock, has been featured in Pharma Times’ latest issue, where he discusses how embracing next-generation, AI-driven process automation supports pharma with ongoing

Qinecsa CEO, Adam Sherlock, has been featured in Pharma Tech Outlook Europe’s latest issue, where he discusses how turning pharmacovigilance from a reactive function into